- Report
- August 2022
- 600 Pages
Global
From €2362EUR$2,550USD£1,981GBP
€2779EUR$3,000USD£2,331GBP
- Report
- June 2022
- 1500 Pages
Global
From €3070EUR$3,315USD£2,575GBP
€3612EUR$3,900USD£3,030GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2362EUR$2,550USD£1,981GBP
€2779EUR$3,000USD£2,331GBP
- Report
- February 2022
- 360 Pages
United States
From €2834EUR$3,060USD£2,377GBP
€3334EUR$3,600USD£2,797GBP
- Report
- December 2021
- 120 Pages
Global
From €2598EUR$2,805USD£2,179GBP
€3057EUR$3,300USD£2,564GBP
- Report
- November 2021
- 222 Pages
Global
From €2362EUR$2,550USD£1,981GBP
€2779EUR$3,000USD£2,331GBP
- Report
- October 2021
- 78 Pages
Global
From €741EUR$800USD£622GBP
- Report
- December 2021
- 296 Pages
Global
From €4863EUR$5,250USD£4,079GBP
- Report
- June 2023
- 361 Pages
Global
From €5094EUR$5,500USD£4,273GBP
- Report
- May 2023
- 240 Pages
Global
From €5094EUR$5,500USD£4,273GBP
- Report
- December 2021
- 353 Pages
Global
From €2547EUR$2,750USD£2,136GBP
€5094EUR$5,500USD£4,273GBP
- Report
- September 2021
- 258 Pages
Global
From €2547EUR$2,750USD£2,136GBP
€5094EUR$5,500USD£4,273GBP
- Report
- September 2021
- 143 Pages
Global
From €2547EUR$2,750USD£2,136GBP
€5094EUR$5,500USD£4,273GBP
- Report
- January 2022
- 292 Pages
Global
From €3473EUR$3,750USD£2,913GBP
- Report
- May 2023
United States
From €1389EUR$1,500USD£1,165GBP
- Report
- March 2023
Germany
From €1389EUR$1,500USD£1,165GBP
- Report
- November 2022
- 197 Pages
United States
From €3473EUR$3,750USD£2,913GBP
- Report
- September 2023
- 324 Pages
Global
From €4585EUR$4,950USD£3,846GBP
- Report
- July 2023
- 236 Pages
Global
From €4585EUR$4,950USD£3,846GBP
- Report
- January 2023
- 356 Pages
Global
From €4585EUR$4,950USD£3,846GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more